Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation.
about
Ankyrin and the hemolytic anemia mutation, nb, map to mouse chromosome 8: presence of the nb allele is associated with a truncated erythrocyte ankyrinThe Cebpd (C/EBPdelta) gene is induced by luteinizing hormones in ovarian theca and interstitial cells but is not essential for mouse ovary function.Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators.Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice.Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?Extracellular proteolysis in the adult murine brainRetinoic acid-mediated activation of HNF-3 alpha during EC stem cell differentiationMasking, unmasking, and regulated polyadenylation cooperate in the translational control of a dormant mRNA in mouse oocytes.Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney.Characterization of 125I-tissue plasminogen activator binding to cerebellar granule neuronsPlasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involutionIn vivo antisense oligodeoxynucleotide mapping reveals masked regulatory elements in an mRNA dormant in mouse oocytes.Transcription factor Sp1 is important for retinoic acid-induced expression of the tissue plasminogen activator gene during F9 teratocarcinoma cell differentiationDifferentiation-responsive elements in the 5' region of the mouse tissue plasminogen activator gene confer two-stage regulation by retinoic acid and cyclic AMP in teratocarcinoma cells.Adenovirus E1A-mediated negative control of genes activated during F9 differentiation.Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells.Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.The kidney is a major site of alpha(2)-antiplasmin production.Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.Adenovirus infection of differentiated F9 cells results in a global shut-off of differentiation-induced gene expressionIn vitro analysis of the tissue plasminogen activator promoter reveals a GC box-binding activity present in murine brain but undetectable in kidney and liver.
P2860
Q28509107-C620AD20-A05C-48BA-9182-43B1F3B76F65Q33311281-6A256CDC-6B4A-4075-8BAA-265DBDF46615Q33680725-3A24FAE4-2FA8-42CA-893D-7306E44B3F2FQ33890990-C24721D7-4BE7-48DE-A200-99A8C88141DBQ34018715-6DE778EC-4C4D-45D0-8CB6-5F005252BA22Q34170437-4632B2E5-34BA-4848-BBE9-EE4D1E6FA00EQ34841198-740DC135-4E1F-42D1-9102-D75B0C01B5C0Q35207870-65D1B756-8425-47AD-95A4-D4F12BE736B0Q35819933-B3B15D24-15F6-4F6C-80BE-5FBC8232B413Q36220261-429E18E7-C265-4106-B21A-D6961D58518FQ36221987-7E93A2B5-07B6-49F9-94B5-5FFA522E9C43Q36531772-154D43ED-63C1-43C4-999B-7C5DECABE78DQ36567386-ACDC16AC-94E7-4F77-9FE5-661078AEF5DBQ36733082-A6A1D3CD-6A8D-4DBD-B4AE-B131329A2B7AQ36764351-C40D2AC0-7120-49D6-AEB4-F1EF2FEEEAF9Q36770305-9D3E1881-CDA0-4CA6-925E-35A72FE3CD30Q36884889-4F90C880-0663-4622-9B6F-CFBBD04F18E5Q37355459-620D6953-0C7C-4F97-B5DF-FBF91E423E8EQ37355545-48D19948-7819-40E1-8B10-0E8D73C384FBQ37498347-D1F6CC2C-3EE9-49FD-9685-678A3A081C2FQ37561638-28ACB3B0-85A5-4CEF-9E3F-5F968FBBDB0DQ39808694-A3DCAA0F-14DC-46BB-A3C0-A9753F82A1CBQ40525047-AD41A06F-CEF7-404A-98CF-2A1473152B7CQ41860417-8941BAAD-1514-4212-9FC0-88B0967F5343
P2860
Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Molecular cloning of complemen ...... arcinoma cell differentiation.
@ast
Molecular cloning of complemen ...... arcinoma cell differentiation.
@en
type
label
Molecular cloning of complemen ...... arcinoma cell differentiation.
@ast
Molecular cloning of complemen ...... arcinoma cell differentiation.
@en
prefLabel
Molecular cloning of complemen ...... arcinoma cell differentiation.
@ast
Molecular cloning of complemen ...... arcinoma cell differentiation.
@en
P2093
P1476
Molecular cloning of complemen ...... arcinoma cell differentiation.
@en
P2093
Rickles RJ
Strickland S
P304
P407
P577
1988-01-01T00:00:00Z